Target intelligence / Profile preview

TBC1 domain family, member 2B pseudogene

Molecular classification: Other (Pseudogene)

Overview

The TBC1 domain family, member 2B pseudogene is a non-coding genomic region related to the active *TBC1 domain family member 2B*. Pseudogenes are traditionally characterized by their sequence similarity to functional genes but lack protein-coding potential due to disabling mutations or deletions. Consequently, this pseudogene does not encode an active protein, is not implicated in biological pathways, and has no recognized therapeutic relevance. For disease associations or therapeutic targeting, refer to the protein-coding gene TBC1D2B, which is involved in GTPase regulation, endosomal trafficking, and is associated with neurodevelopmental disorders and gingival fibromatosis[3][4][6].

Other names: TBC1D2B pseudogene

Beyond the preview

Go deeper on TBC1 domain family, member 2B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family, member 2B pseudogene.

Explore the full profile